Capoten

DRUG2 trials

Sponsors

GlaxoSmithKline, Baylor Research Institute

Conditions

Chronic Kidney DiseaseHealthy VolunteersType 2 Diabetes

Phase 1

Bioequivalence Study Between Capoten Versus Captopril Reference Product in Healthy Adult Participants Under Fasting Conditions

WithdrawnNCT04878315

GlaxoSmithKlineHealthy Volunteers

Start: 2022-02-13End: 2022-03-25Updated: 2023-01-27

Phase 4

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Not yet recruitingNCT07547878

Baylor Research InstituteChronic Kidney Disease, Type 2 Diabetes

Start: 2026-04-30End: 2029-03-31Target: 64Updated: 2026-05-08